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Abstract: Immune system deterioration in space represents a major risk, which has to be mitigated
for exploration-class missions into the solar system. Altered gravitational forces have been shown to
regulate adaptation processes in cells of the immune system, which are important for appropriate
risk management, monitoring and development of countermeasures. T lymphocytes and cells of
the monocyte-macrophage system are highly migratory cell types that frequently encounter a wide
range of oxygen tensions in human tissues and in hypoxic areas, even under homeostatic conditions.
Hypoxia-inducible factor 1 and 2 (HIF’s) might have an important role in activation of T cells and cells
of the monocyte-macrophages system. Thus, we investigated the regulation of HIF-dependent and,
therefore, hypoxia-signaling systems in both cell types in altered gravity and performed transcript
and protein analysis from parabolic flight and suborbital ballistic rocket experiments. We found
that HIF-1α and HIF-1-dependent transcripts were differently regulated in altered gravity, whereas
HIF-1α-dependent gene expression adapted after 5 min microgravity. Inter-platform comparisons
identified PDK1 as highly responsive to gravitational changes in human U937 myelomonocytic cells
and in Jurkat T cells. We suggest HIF-1 as a potential pharmacological target for counteracting
immune system deterioration during space flight.
Keywords: gene expression; immune system; oxygen; microgravity
1. Introduction
The immune system deteriorates during long-term space flights, probably contributing to an
increased susceptibility to infection, autoimmunity, and cancer during exploration-class missions [1–5].
Physiological systems strongly respond to altered gravitational forces and adapt to the new
gravitational environment within hours until weeks [1]. Cellular and molecular processes are
also severely affected in microgravity, including morphology, cell proliferation and differentiation,
signal transduction and gene expression (reviewed in [2]) and understanding them is an essential
condition for an integrated risk assessment for exploration-class space missions [3]. This is in line with
the recommendation of the National Aeronautics and Space Administration (NASA) Inspector General
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report that potential immune system deterioration in space requires risk mitigation measures in
preparation for exploration-class missions into the solar system [4] and of the U.S. National Academies
of Science, Engineering and Medicine to investigate more carefully the reversibility of the changes
that occur during and after flight [5]. Knowledge about molecular and cellular responses to altered
gravity represents crucial information for medical monitoring, development of countermeasures and
appropriate risk management of human health and performance-limiting factors during manned
space exploration.
T lymphocytes are a highly migratory cell type of the adaptive immune system that frequently
encounters a wide range of oxygen tensions in human tissues and in hypoxic areas even under
homeostatic conditions [6]: T cells are present in a hypoxic environment in bone marrow [7], spleen [8],
in the gastrointestinal tract [9] and following inflammation [10,11]. Effector T cells present at sites of
inflammation or retained within non-lymphoid tissues have a high probability of prolonged exposure
to a hypoxic environment [6], for example in inflammatory lesions during inflammatory bowel
diseases [12] or rheumatoid arthritis [13]. It has been demonstrated that oxygen availability regulates
T cell differentiation and function, a response orchestrated in large part by the hypoxia-inducible factor
transcription factors [6].
Since mammals, including man, are crucially dependent on oxygen to fuel their highly active
metabolism, any shortage of oxygen is an alarm situation for any mammalian cell. Consequently,
evolution developed a rapid cellular sensor system that is able to change the gene-expression profile in
hypoxic cells instantaneously [14]. The underlying sensor system for this acute response to hypoxia is
based on heterodimeric proteins, called hypoxia-inducible factors (HIFs), of which the α-subunits are
continuously produced and degraded in the presence of oxygen. During hypoxia, either HIF-1α for
most rapid responses or HIF-2α for more delayed ones, both of them representing the master regulators
of the cellular response to oxygen shortage, are stabilized and translocated to the nucleus to form
HIF transcription complexes that bind the hypoxia response element (HRE) present in the promoter
of oxygen-dependent regulated genes. Each HIF is a heterodimer composed of the constitutively
expressed β subunit and an α subunit whose stability depends on the oxygen level [15]. During
normoxia, HIF-1α and HIF-2α are hydroxylated by prolyl hydroxylases (PHDs), recognized by the
von-Hippel–Lindau (VHL) factor, ubiquitinated and degraded by the proteasome. Under hypoxic
conditions this mechanism is inactive and HIF-α proteins are not degraded and translocated to the
nucleus to form a transcription complex with the HIFβ subunit [16] that induces transcription of genes
mediating cellular adaptation to a low oxygen [15]. HIFs can also be stabilized and exert their activity
under normoxic conditions in response to bacterial products, cytokines, inflammatory mediators
and stress [17]. In the last decades a huge number of oxygen-dependent regulated genes has been
identified underlining the importance of this fundamental biological process. Of note, regulation of
oxygen-dependent genes occurs almost continuously somewhere in our body and is of significant
importance in key physiological processes such as angiogenesis, regulation of red blood cell mass,
wound healing or defense against infections [18,19]. Noteworthy, after stabilization of the HIF protein,
the response to hypoxia requires rapid nuclear transfer of HIF that is dependent on the cytoskeleton to
trigger the transcription of hypoxia-inducible genes [20] and gravitational changes have immediate
impact on the cytoskeleton [21]. In addition to transcriptional regulation, gene expression can be
controlled via retention or release of transcribed mRNA in response to various types of cellular
stress [22–24] and this has also been demonstrated for HIF-dependent transcripts [24].
HIF-1α has been identified as a regulator of T cell responses [10,25], which is induced
STAT3-dependent in naive CD4 T cells, even in the presence of oxygen [16] and promotes expression
of several Th17-linked genes [26]. Thus, elevated HIF-1 levels, stabilized by either cytokine or
T cell receptor (TCR) signaling or hypoxic conditions, should promote a strong and enduring Th17
response [16]. HIF-1 drives the expression of a number of genes necessary for the shift to a glycolysis
dominated metabolism [27,28], resulting in metabolic reprogramming of T cells [29,30]. HIF-1-induced
signaling pathways during metabolic reprogramming includes mTOR and PI3K/Akt [31]. Also, Notch
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signaling and antiapoptotic gene expression are under the control of HIF-1 [32]. Therefore, HIF-1α
might have an important role in T cell activation and differentiation programs beyond its well-known
role in coordinating hypoxic responses [6].
In the monocyte-macrophage-system, HIF promotes bactericidal activities and supports the innate
immune functions [33]. A hypoxic microenvironment imposes a metabolic adaptation to macrophages,
skewing their functions towards a mitogenic, pro-invasive and pro-angiogenic phenotype [33].
In damaged tissues, HIF-1α and HIF-2α are up-regulated in macrophages, where they orchestrate
post-infarction remodeling [34].
Thus, the question arises, whether and how microgravity interferes with HIF-dependent and,
therefore, hypoxia signaling systems in T cells and cells of the monocyte-macrophage system. Therefore,
we employed three different cell lines, two for transcript analysis and one for quantifying cellular
HIF-1α protein content in response to hypergravity (1.8 g to 13.5 g) as well as in microgravity (µg)
and conducted experiments on board parabolic flights and during suborbital ballistic rocket missions.
We found that the HIF-1α and hypoxia-inducible transcripts were differently regulated in altered
gravity, whereas HIF-1α-dependent gene expression adapted after 5 min microgravity. Our data
indicate that HIF-1α and subsequent signaling pathways are significantly regulated by altered gravity.
2. Results
2.1. Altered Gravity Regulates Hypoxia-Inducible Factor (HIF)-1α-Dependent Gene Expression in Human
Jurkat T Cells and Myelomonocytic U937 Cells and HIF-1α Protein Content in MDA-MB468 cells
HIF-1α is a rapid master transcriptional regulator of the adaptive response to hypoxia and
continuously produced and degraded in the presence of oxygen. Thus, even slight imbalances
between production and degradation will alter the cellular HIF-1α protein content and subsequently
HIF-1α-dependent gene expression. We used MDA-MB-468 cells during the first Swiss Parabolic
Flight Campaign to assess whether gravitational stress may change cellular HIF-1α protein content.
MDA-MB-468 cells are a commonly used model in the study of cellular response to hypoxia [35].
Cells were harvested after being subjected to 20 s of hypergravity (1.8 g) followed by 20 s of
microgravity during the first parabola of the first Swiss Parabolic Flight Campaign. Another set of cells
was harvested at the end of the 15th parabola. Protein extracts were analyzed using semi-quantitative
Western blotting [36]. Compared to the control conditions (i.e., in 1 g in-flight condition before the first
parabola), cellular HIF-1α protein content after the first parabola was significantly about 40% lower
and remained low until the last (15th) parabola (Figure 1).
Int. J. Mol. Sci. 2019, 20, x 3 of 30 
 
Therefore, HIF-1α might have an important role in T cell activation and differentiation programs 
beyond its well-known role in coordinating hypoxic responses [6]. 
In the monocyte-macrophage-system, HIF promotes bactericidal activities and supports the 
innate immune functions [33]. A hypoxic microenvironment imposes a metabolic adaptation to 
macrophages, skewing their functions towards a mitogenic, pro-invasive and pro-angiogenic 
phenotype [33]. In damaged tissues, HIF-1α and HIF-2α are up-regulated in macrophages, where 
they orchestrate post-infarction remodeling [34]. 
Thus, th  question arises, w ther and how microgravity interferes with HIF-de  , 
therefore, hypoxia signaling systems in T cells and cells of th  onocyte-macrophage system. 
Therefore, we mploy d three different cell lines, two for tr nscript analysis and one for quantifying 
cellular HIF-1α protein conte t in response to hypergravity ( .8 g to 13.5 g) as well as in microgravity 
(µg) and conducted experiments on board parabolic flights and during suborbital ballistic rocket 
missions. We found that the HIF-1α and hypoxia-inducible transcripts were differently regulated in 
altered gravity, whereas HIF-1α-dependent gene expression adapted after 5 min microgravity. Our 
data indicate that HIF-1α and subsequent signaling pathways are significantly regulated by altered 
gravity. 
2. Results 
2.1. Altered Gravity Regulates Hypoxia-Inducible Factor (HIF)-1α-Depe de t Gene Expression in Human 
Jurkat T Cells and Myelomonocytic U937 Cells and HIF-1α Protein Content in MDA-MB468 cells 
HIF-1α is a rapid master transcriptional regulator of the adaptive response to hypoxia and 
continuously produced and degraded in the presence of oxygen. Thus, even slight imbalances 
between production and degradation will alter the cellular HIF-1α protein content and subsequently 
HIF-1α-dependent gene expression. We used MDA-MB-468 cells during the first Swiss Parabolic 
Flight Campaign to assess whether gravitational stress may change cellular HIF-1α protein content. 
MDA-MB-468 cells are a commonly used model in the study of cellular response to hypoxia [35]. 
Cells were harvested after being subjected to 20 s of hypergravity (1.8 g) followed by 20 s of 
microgravity during the first parabola of the first Swiss Parabolic Flight Campaign. Another set of 
cells was harvested at the end of the 15th parabola. Protein extracts were analyzed using semi-
quantitative Western blotting [36]. Compared to the control conditions (i.e., in 1 g in-flight condition 
before the first parabola), cellular HIF-1α protein content after the first parabola was significantly 
about 40% lower and remained low until the last (15th) parabola (Figure 1). 
 
Figure 1. Average optical density of hypoxia-inducible factor (HIF)-1α-positive bands in Western 
blots of protein extracts from MDA-MB-468 cells normalized to total protein of the conditions as 
indicated. Compared to the control conditions (i.e., in 1 g in-flight condition before the first parabola) 
HIF-1α expression after the 1st parabola was significantly (* = p < 0.05) about 40% lower and stayed 
this low until the last (15th) parabola although there was a slight trend to a recovery of the HIF-1α 
expression (p = 0.075 vs. control). 
Figure 1. Average optical density of h poxia-inducible factor (HIF)-1α-positive bands i Western blots
of protein extracts from MDA-MB-468 cells normalized to total protein of the conditions as indicated.
Compared to the control conditions (i.e., in 1 g in-flight condition before the first parabola) HIF-1α
expression after the 1st parabola was significantly (* = p < 0.05) about 40% lower and stayed this low
until the last (15th) parabola although there was a slight trend to a recovery of the HIF-1α expression
(p = 0.075 vs. control).
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Therefore, in a next step we used the data of four different microgravity campaigns to analyze
hyper- and microgravity short term and midterm effects of gravitational alterations on HIF-1α-RNA
expression and expression of numerous HIF1α-dependently regulated genes. Parabolic flights were
used for the analysis of short-term altered gravity effects and suborbital rocket flights to detect time
dependent dynamic adaptation processes within minutes (Table 1).
Table 1. Experiment group description of the parabolic flight campaigns (PFC) (19th and 23rd
German Aerospace Center (DLR)) and the sounding rocket campaigns (Technologische Experimente
unter Schwerelosigkeit (TEXUS) TEXUS-49 and TEXUS-51). Maximum g-level and altered gravity
times are given in brackets. BL = Baseline, hyp-g = hypergravity, µg = microgravity, IF = in flight,
H/W= hardware, TX = TEXUS.
Experiment Group Description Gravity Condition 19th DLR PFC23rd DLR PFC
TEXUS-49
TEXUS-51
Cell culture control 1 g n/a CC (TEXUS-51)
Hardware 1 g ground control 1 g H/W 1 g GC H/W 1 g GC
1 g in-flight 1 g 1 g IF 1 g IF (TEXUS-51)
Baseline (BL)/Hypergravity
[directly before µg phase] hyp-g
BL-PFC hyp-g
[1.8 g, 20 s]
BL-TX hyp-g
[max. 13.5 g, 75 s]
Microgravity (µg) µg µg [20 s] µg [300 s]
Experiments were performed with human Jurkat T cells and U937 cells to investigate general
altered gravity induced effects on the transcriptome. As previously described [37–39], human Jurkat
T cells as well as human U937 myelomonocytic cells were exposed to 20 s of hypergravity (1.8 g) and
subsequently to 20 s of microgravity (µg) during the first parabola of a parabolic flight (19th and 23rd
German Aerospace Center (DLR) Parabolic Flight Campaigns (PFC). Cell samples were lysed at the
end of the respective flight phase. Corresponding 1 g in-flight control samples were taken five minutes
before the first parabola, and 1g ground controls (GC) were taken on ground directly after the flight
on board the aircraft under identical conditions except for the gravitational force. In Jurkat T cells
and U937 cells, expression of HIF-1α mRNA was significantly affected when comparing hardware
1 g ground control samples with the hypergravity phase (Jurkat T cells: fold change (FC) = +1.25,
p = 0.000003, U937: FC = −2.01, p = 0.020615). The subsequent microgravity phase showed only
minimal, non-significant alterations of HIF1α expression (Figure 2). During the sounding rocket
experiments (Technologische Experimente unter Schwerelosigkeit (TEXUS)) TEXUS-49 and TEXUS-51,
hypergravity samples were acquired 75 s after lift-off, at the end of the hypergravity phase and after
five minutes of microgravity. Ground control samples were performed in identical hardware units
and under identical conditions except for the gravitational force. In case of the TEXUS-51 mission an
on-board centrifuge allowed 1 g in-flight controls during the microgravity phase. Additionally, 1 g
controls under standard cell culture conditions were carried out on the ground to monitor potential
hardware effects on the experiment. In both suborbital ballistic rocket experiments we were able to
identify a significant upregulation of HIF-1α expression after the 75 s hypergravity phase (Jurkat
T cells: FC = +1.66, p = 0.000736, U937: FC = +2.383, p = 0.002885) and a tendency to recover after 5 min
of microgravity (Figure 3). For the parabolic flight and suborbital rocket campaigns, a minimum of
four RNA samples for each experiment group was isolated and processed for microarray analyses (see
Materials and Methods).
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2.2. Analysis of Hypoxia-Inducible Factor 1α Gene Expression
The differential gene expression of Hypoxia-inducible factor 1α (HIF-1α) was analyzed in detail
for the different phases of a parabolic flight. Figure 2a shows the gene expression of HIF-1α measured
in human Jurkat T cells. Interestingly, the force environment during the take-off and steady flight phase
of the aircraft (<1.3 g, and vibrations of <±0.09 g) contributed already to a significant up-regulation
of gene expression. The exposure of the cells to the first hypergravity phase increased this effect
(Figure 2a). Exposure of the cells to the following microgravity phase, however, did not further affect
the gene expression level. A similar trend could be observed for human myelomonocytic U937 cells.
Again, the hypergravity generated during the take-off already influenced the HIF-1α gene expression
and this effect was increased during the hypergravity phase of the first parabola (Figure 2b). However,
the HIF-1α gene expression was downregulated in this cell type. As seen for the human Jurkat T cells,
the following 20 s microgravity phase did not reverse or further influence this effect.
When we analyzed the midterm effects of altered gravity on the gene expression of human
Jurkat T cells on a suborbital rocket flight, we also identified an up-regulation of HIF-1α after 75 s of
hypergravity and a stable gene expression with a tendency to a counter-regulation in the subsequent
microgravity phase (Figure 3a). In the human myelomonocytic U937 cells, we also identified an
up-regulation of HIF-1α gene expression after 75 s of hypergravity with a rapid counter-regulation in
the following microgravity phase (Figure 3b). The altered gravity-based transcriptome changes
could be confirmed by measurements of HIF-1α protein expression levels in the breast cancer
cell line MDA-MB-468 performed in an independent hardware on the First Swiss Parabolic Flight
(Figure 1). In accordance with the gene expression data of the human myelomonocytic U937 cells
we identified a down-regulation of the protein content (Figure 1), which suggests together with the
aforementioned RNA-data that also HI-F1α-dependent gene expression might be altered in different
gravitational environment.
2.3. Analysis of Hypoxia-Inducible Factor-Related Genes
This rapid reactivity of HIF-1α mRNA and protein to altered gravity encouraged us to extend
the gene expression analysis to HIF-1α-regulated genes. In total, we selected 176 HIF-related genes
(Supplementary Table S1). These are represented by 375 probe sets on the applied NimbleGen arrays
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based on the hg18 annotation, used for analysis of the U937 cells; 175 of the 176 genes (one gene
was not present on the array) are represented by 184 transcript clusters (for simplicity also referred
to as probe sets in this paper) on the Affymetrix GeneChip® Human Transcriptome Array (Thermo
Fisher Scientific, Waltham, MA, USA) used for analysis of the Jurkat T cells. For the respective
gravity conditions, the differential gene expression was analyzed and expression changes between
microgravity and hypergravity samples and the corresponding control samples were determined
(Tables 2–5 and 7–10, Supplementary Tables S2–S5). During PFC and suborbital ballistic rocket missions,
the first altered gravity condition is always represented by a hypergravity phase including other
conditions like hardware effects on cell cultivation, temperature changes, and vibrations. This phase is
followed by the microgravity phase. In order to avoid including prolonged or delayed hypergravity
effects in the groups of microgravity-sensitive transcripts, probe sets that were expressed in the same
direction as in the preceding hypergravity phase were excluded and the results are termed “controlled”
versions. The probe sets were grouped into “no response” (no significant changes), “continuous
response” (changes in the same direction compared to the initial response), “adaptation” (changes
in the opposite direction compared to the initial response), and “late response” (no response after
20 s, but later significant response) according to duration and quality of the response to the respective
gravity condition. The HIF signaling related and differentially regulated probe sets of the mentioned
categories were further investigated to identify their time dependent response to the different altered
gravity conditions.
2.4. Rapid Alterations of HIF-Related Genes after 20 s of Altered Gravity in Human Jurkat T cells
Already after take-off of the airplane and the associated hypergravity and vibration conditions,
65% of the HIF-related probe sets (114 out of 175) were significantly differentially expressed
(comparison 1 g in flight (IF) versus hardware (H/W) 1 g ground control (GC)). In human Jurkat T
cells 38 differentially regulated HIF-related probe sets showed a response within 20 s of hypergravity
(hyp-g) during the first parabola (comparison of experiment groups baseline/hypergravity (BL-PFC
hyp-g) versus 1 g IF, Table 2); 27 of these 38 probe sets, i.e., 71%, overlap with the 114 initially identified
probe sets from the comparison 1 g IF versus H/W 1 g GC. After the subsequent first microgravity
phase, 14 probe sets (microgravity (µg) versus BL-PFC hyp-g) were differentially expressed. When the
number of hypergravity-sensitive probe sets was determined with respect to the H/W 1 g GC control
group, 70 differentially expressed probe sets were identified (Figure 4, Tables 2 and 3). After exclusion
of the probe sets that were already altered in the control comparison (differentially expressed in the
same direction of the comparisons µg versus BL-PFC hyp-g and BL-PFC hyp-g versus H/W 1 g GC),
we revealed 10 microgravity-sensitive probe sets (µg versus BL-PFC hyp-g) (Figure 4 and Table 3).
The analysis of probe sets double-sensitive for hyper- and microgravity (BL-PFC hyp-g versus H/W
1 g GC and µg versus BL-PFC hyp-g), revealed four probe sets being differentially regulated in the
same direction and no probe set that was expressed in the opposite direction (Figure 4). The maximum
and minimum expression fold change (FC) values for hypergravity-sensitive probe sets were +1.39 and
–1.62, with average figures of +1.15 and −1.17, respectively. The maximum and minimum expression
FC values for microgravity sensitive probe sets were +1.11 and −1.07, with average figures of +1.08
and −1.04, respectively (Table 3).
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Table 2. Numbers of differentially expressed probe sets in response to altered gravitational conditions
in Jurkat T cells during the 23rd DLR PFC. Direct primary comparisons between the sample groups
are shown.
Primary Comparisons
Gene Expression 1 g IF vs. H/W1 g GC
BL-PFC hyp-g vs.
1 g IF
µg vs. BL-PFC
hyp-g
BL-PFC hyp-g vs.
H/W 1 g GC
up-regulated 85 19 3 51
down-regulated 29 19 11 19
total 114 38 14 70
Int. J. Mol. Sci. 2019, 20, x 8 of 30 
 
 
Figure 4. Strategy for the identification of microgravity- and hypergravity-sensitive probe sets in 
human Jurkat T cells during the 23rd DLR PFC. The different comparisons and resulting intersections 
for hypergravity and microgravity-sensitive probe sets are displayed as Venn-diagrams. In the circles 
numbers of probe sets are given that are differentially expressed with a p-value < 0.05. The red area 
shows the number of BL-controlled (BL-PFC hyp-g versus H/W 1 g GC) microgravity-sensitive 
transcripts: differentially expressed in the comparison µg versus BL-PFC hyp-g excluding those 
differentially expressed in the control comparison BL-PFC hyp-g versus H/W 1 g GC that are 
regulated in the same direction. For the abbreviations of the experiment group names see Table 1. 
Table 3. Definition and numbers of hypergravity- and microgravity-sensitive probe sets that are 
differentially expressed in response to hypergravity or microgravity in Jurkat T cells during parabolic 
flight. 
Gene 
Expression 
Hypergravity-Sensitive Probe Sets Microgravity-Sensitive Probe Sets 
 
Significantly differentially expressed in the 
primary comparison BL-PFC hyp-g vs H/W 1 
g GC 
Significantly differentially expressed in the primary 
comparison µg vs BL-PFC hyp-g 
NOT significantly expressed in the same direction in 
the primary comparisons µg vs BL-PFC hyp-g and 
BL-PFC hyp-g vs H/W 1 g GC 
 Number 
average FC of 
BL-PFC hyp-g 
vs 1 g IF 
min/max FC of 
BL-PFC hyp-g vs 
H/W 1 g GC 
Number 
average FC µg 
vs BL-PFC 
hyp-g 
min/max µg vs BL-
PFC hyp-g 
up-regulated 51 1.15 1.39 3 1.08 1.11 
down-regulated 19 −1.17 −1.62 7 −1.04 −1.07 
total 70 - - 10 - - 
2.5. Strong Response of HIF-Related Genes in Human Jurkat T Cells After 75 s of Hypergravity but Not 
After 300 s of Microgravity 
During the launch phase of the suborbital ballistic rocket experiment, human Jurkat T cells 
responded rapidly within 75 s covering the hypergravity phase with a total number of 123 
differentially regulated HIF-related probe sets (comparison baseline/hypergravity (BL-TX hyp-g) 
versus H/W 1 g GC, Tables 4 and 5, Figure 5). After the subsequent 300 s microgravity phase, only 9 
probe sets were differentially expressed (µg versus BL-TX hyp-g, Tables 4 and 5, Figure 5), which is 
13.6-fold lower than the number of differentially expressed probe sets in hypergravity. Interestingly 
and compared to the parabolic flight experiments, here none of the identified probe sets was 
hypergravity and microgravity double-sensitive (BL-TX hyp-g versus H/W 1 g GC and µg versus BL-
TX hyp-g) (Figure 5). The expression fold change (FC) was in the range between +1.76 (up-regulation) 
and −1.35 (down-regulation), with average values of +1.26 and −1.14, respectively, for the 
hypergravity-sensitive probe sets and between +1.08 (up-regulation) and −1.15 (down-regulation) 
with average values of +1.05 and −1.10, respectively, for microgravity-sensitive probe sets (Table 5). 
Note that in these experiments with a much stronger and longer hypergravity phase, the number of 
hypergravity sensitive genes is far higher than in parabolic flight experiments (Table 3). 
Figure 4. Strategy for the identification of microgravity- and hypergravity-sensitive probe sets in
human Jurkat T cells during the 23rd DLR PFC. The different comparisons and resulting intersections
for hypergravity and microgravity-sensitive probe sets are displayed as Venn-diagrams. In the circles
numbers of probe sets are given that are differentially expressed with a p-value < 0.05. The red
area shows the number of BL-controlled (BL-PFC hyp-g versus H/W 1 g GC) microgravity-sensitive
transcripts: differentially expressed in the comparison µg versus BL-PFC hyp-g excluding those
differentially expressed in the control comparison BL-PFC hyp-g versus H/W 1 g GC that are regulated
in the same direction. For the abbreviations of the experiment group names see Table 1.
Table 3. Definition and numbers of hypergravity- and microgravity-sensitive probe sets that
are differentially expressed in response to hypergravity or microgravity in Jurkat T cells during
parabolic flight.
Gene
Expression Hypergravity-Sensitive Probe Sets Microgravity-Sensitive Probe Sets
Significantly differentially expressed in the
primary comparison BL-PFC hyp-g vs. H/W
1 g GC
Significantly differentially expressed in the
primary comparison µg vs. BL-PFC hyp-g
NOT significantly expressed in the same direction
in the primary comparisons µg vs. BL-PFC hyp-g
and BL-PFC hyp-g vs. H/W 1 g GC
Number
average FC of
BL-PFC hyp-g
vs. 1 g IF
min/max FC of
BL-PFC hyp-g
vs. H/W 1 g GC
Number average FC µg vs.BL-PFC hyp-g
min/max µg vs.
BL-PFC hyp-g
up-regulated 51 1.15 1.39 3 1.08 1.11
down-regulated 19 −1.17 −1.62 7 −1.04 −1.07
total 70 - - 10 - -
2.5. Strong Response of HIF-Related Genes in Human Jurkat T Cells After 75 s of Hypergravity but Not After
300 s of Microgravity
During the launch pha e of the suborbital ballistic rock t experi ent, human Jurkat T cells
responded rapidly within 75 s covering the hypergravity phase with a total number of 123 differentially
regulated HIF-related probe sets (comparison baseline/hypergravity (BL-TX hyp-g) versus H/W 1
Int. J. Mol. Sci. 2019, 20, 436 9 of 31
g GC, Tables 4 and 5, Figure 5). After the subsequent 300 s microgravity phase, only 9 probe sets
were differentially expressed (µg versus BL-TX hyp-g, Tables 4 and 5, Figure 5), which is 13.6-fold
lower than the number of differentially expressed probe sets in hypergravity. Interestingly and
compared to the parabolic flight experiments, here none of the identified probe sets was hypergravity
and microgravity double-sensitive (BL-TX hyp-g versus H/W 1 g GC and µg versus BL-TX hyp-g)
(Figure 5). The expression fold change (FC) was in the range between +1.76 (up-regulation) and −1.35
(down-regulation), with average values of +1.26 and −1.14, respectively, for the hypergravity-sensitive
probe sets and between +1.08 (up-regulation) and−1.15 (down-regulation) with average values of +1.05
and −1.10, respectively, for microgravity-sensitive probe sets (Table 5). Note that in these experiments
with a much stronger and longer hypergravity phase, the number of hypergravity sensitive genes is
far higher than in parabolic flight experiments (Table 3).
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Figure 5. Strategy for the identification of hypergravity- and microgravity-sensitive probe sets from
human Jurkat T cells during the TEXUS-51 sounding rocket flight. The different comparisons for
hypergravity and microgravity-sensitive probe sets are displayed as Venn-diagrams. In the circles
numbers of probe sets are given that are differentially expressed with a p-value < 0.05. The red area
shows the number of microgravity-sensitive probe sets. There is no overlap between the identified
probe sets for the comparisons µg versus BL-TX hyp-g and BL-TX hyp-g versus H/W 1 g GC. For the
abbreviations of the experiment group names see Table 1.
Table 4. Numbers of differentially expressed probe sets in response to altered gravity conditions in
Jurkat T cells during TEXUS-51 sounding rocket flight. Direct comparisons between the sample groups
are shown.
Primary Comparisons
Gene
Expression
1 g IF vs.
H/W 1 g GC
BL-TX hyp-g
vs. 1 g IF
µg vs. BL-TX
hyp-g µg vs. 1 g IF
BL-TX hyp-g vs.
H/W 1 g GC
H/W 1 g GC
vs. CC
up-
regulated 29 37 5 33 41 125
down-
regulated 5 114 4 109 82 52
total 34 151 9 142 123 177
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Table 5. Identification of hyper- and microgravity-sensitive probe sets representing genes involved in
HIF-1 signaling pathway in response to altered gravity conditions during TEXUS-51 sounding rocket
flight in Jurkat T cells.
Gene
Expression Hypergravity-Sensitive Probe Sets Microgravity-Sensitive Probe Sets
Significantly differentially expressed in the primary
comparison BL-TX hyp-g vs. H/W 1 g GC
Significantly differentially expressed in the
primary comparison µg vs. BL-TX hyp-g
NOT significantly expressed in the same direction
in the primary comparisons µg vs. BL-TX hyp-g
and BL-TX hyp-g vs. H/W 1 g GC
Number
average fold
change (FC) of
BL-TX hyp-g vs.
H/W 1 g GC
min/max FC of
BL-TX hyp-g vs.
H/W 1 g GC
Number average FC µgvs. BL-TX hyp-g
min/max µg vs.
BL-TX hyp-g
up-regulated 41 1.26 1.76 5 1.05 1.08
down-regulated 82 −1.14 −1.35 4 −1.10 −1.15
total 123 - - 9 - -
2.6. HIF-Related Genes Were Primarily Differentially Regulated in Hypergravity in Human Jurkat T Cells
Figure 6 summarizes the number of differentially expressed probe sets in the parabolic flight
and suborbital ballistic rocket experiments. Most of the differentially regulated probe sets were
up-regulated after 20 s of hypergravity, whereas only a small fraction of the analyzed probe sets was
differentially regulated at all after 20 s of microgravity (Figure 6a). Longer periods of hypergravity
(75 s 5–7 g) resulted primarily in the down-regulation of probe sets while, after longer periods of
microgravity (5 min 10−4 g), only a few probe sets remained differentially regulated (Figure 6b).
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2.7. Dynamic Reaction and Adaptation Processes of Initially Differentially Altered HIF-Related Genes in
Altered Gravity in Human Jurkat T Cells
The time course of differentially regulated probe sets in 1.8 g and 13.5 g of hypergravity is
summarized in Figure 7, and that of microgravity is summarized in Figure 8. In hypergravity, a total
number of 43 probe sets (23.4%) were not altered at all. Out of 70 initially altered probe sets, after 20 s
in 1.8 g, 21 probe sets (11.4%) were altered in the same direction after 75 s in a maximum of 13.5 g
(Table 6). These 21 probe sets, belonging to 21 genes, were differentially regulated in a continuous
manner after 20 s and 75 s of hypergravity (Table 6). In contrast, 49 probe sets (26.6%) adapted.
Furthermore, 71 probe sets (38.6%) were altered after 75 s in a maximum of 13.5 g, but not after 20 s of
1.8 g of hypergravity.
Interestingly, only a small number of HIF-related probe sets were regulated in the microgravity
phase. A total number of 165 probe sets (90%) were not altered at all. Out of 10 initially altered probe
sets after 20 s, no probe set (0%) was altered in the same direction after 300 s, whereas all 10 initially
differentially expressed probe sets (5.4%) adapted. A further nine probe sets (4.9%) were altered after
300 s, but not after 20 s of microgravity. Thus, in our experiments, which have been conducted on
two different experimental platforms (23rd DLR parabolic flight campaign and TEXUS-51 suborbital
ballistic rocket campaign), we identified two pools of altered probe sets: a first one, which responded
after seconds and adapted within 5 min at the latest, and a second one, which appeared not before
5 min of altered gravity.
Table 6. Differentially regulated probe sets in a continuous manner in 20 s and 75 s of hypergravity
identified in human Jurkat T cells in the 23rd DLR parabolic flight and TEXUS-51 suborbital ballistic
rocket campaigns; 21 probe sets, belonging to 21 genes were differentially regulated with respect to
both altered gravity platforms. Plus: significantly up-regulated probe sets (p-value < 0.05), minus:
significantly down-regulated probe sets (p-value < 0.05). FCs are ratios between the averages of linear
expression values. If the ratio is <1, FC is calculated as the negative reciprocal of the ratio. For the
abbreviations of the group names see Table 1.
Gene Name Gene ID Probe Set ID
Fold Change 23rd
DLR PFC BL-PFC
hyp-g vs. H/W 1 g GC
Fold Change
TEXUS-51 BL-TX
hyp-g vs. H/W 1 g GC
SLC2A1 6513 TC01002578.hg.1 −1.11 −1.03
PIK3R3;
RP11-322N21.2 8503 TC01002616.hg.1 +1.05 +1.3
ARNT 405 TC01003212.hg.1 +1.15 +1.1
PDK1 5163 TC02001031.hg.1 +1.07 +1.17
VHL 7428 TC03000055.hg.1 +1.07 +1.17
PIK3CA 5290 TC03000951.hg.1 +1.18 +1.63
CAMK2D 817 TC04001486.hg.1 +1.11 +1.06
MAPK14 1432 TC06000523.hg.1 +1.08 +1.14
IFNGR1 3459 TC06002152.hg.1 11.13 +1.36
NOS3; ATG9B 4846 TC07001009.hg.1 −1.03 −1.12
RPS6 6194 TC09000938.hg.1 +1.13 +1.32
VIM 7431 TC10000126.hg.1 +1.19 +1.14
CDKN1B 1027 TC12000178.hg.1 +1.38 +1.06
FLT1 2321 TC13000517.hg.1 +1.12 +1.32
HIF1A 3091 TC14002197.hg.1 +1.25 +1.66
MAP2K1 5604 TC15000613.hg.1 +1.3 +1.07
IGF1R 3480 TC15000949.hg.1 +1.18 +1.08
PRKCB 5579 TC16000260.hg.1 +1.06 +1.12
STAT3 6774 TC17001531.hg.1 +1.33 +1.26
AKT2 208 TC19001532.hg.1 −1.08 −1.09
PFKL 5211 TC21000222.hg.1 −1.13 −1.07
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Figure 7. Time course of differential expression of 184 HIF-related probe sets in human Jurkat
T cells after hypergravity exposure (list of probe sets in Supplementary Table S1). Human Jurkat
T cells were exposed to 20 s and 75 s of hypergravity. The probe sets are grouped according to
their regulation after the two exposure times. Continuous response means that the probe sets are
either up-regulated or down-regulated at both time points. Adaptation is either the disappearance
of the hypergravity-induced effect or regulation in the opposite direction after 75 s. Late response
is a regulation that only appears after 75 s. Most of the probe sets show a late response. For the
abbreviations of the experiment group names see Table 1.
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2.8. Rapid Alterations of HIF-Related Genes After 20 s of Altered Gravity in Human U937 Cells 
In human U937 cells we were also able to detect a cellular response at the transcriptome level to 
the hypergravity and vibration effects that is already present during the take-off of the parabolic 
flight aircraft; 45 out of 375 analyzed probe sets (12%) were significantly differentially expressed 
(comparison 1 g in flight (IF) versus hardware (H/W) 1 g ground control (GC)). In contrast to human 
Jurkat T cells, HIF-related probe sets in U937 cells responded even more sensitive to gravitational 
alterations. The hypergravity phase of the first parabola resulted in 104 differentially regulated probe 
sets in the comparison BL-PFC hyp-g versus 1 g IF, a 2.3-fold increase compared to the initial response 
(Table 7). Nine of the 45 initially responding probe sets, overlapped with the 104 regulated probe sets 
identified during the first hypergravity phase (data not shown). In the direct comparison BL-PFC 
hyp-g versus H/W 1 g GC 142 differentially expressed transcripts could be identified (Tables 7 and 8, 
Figure 9). After the subsequent first microgravity phase, only 21 probe sets (µg versus BL-PFC hyp-
g) were differentially expressed (Tables 7 and 8, Figure 9). Note however, that in Jurkat T cells only 
nine probe sets were sensitive under the same condition. No probe set could be excluded based on 
the control comparison: differentially expressed in the same direction of the comparisons µg versus 
BL-PFC hyp-g and BL-PFC hyp-g versus H/W 1 g GC (Figure 9). In the investigation of hypergravity 
and microgravity double-sensitive probe sets (BL-PFC hyp-g versus H/W 1 g GC and µg versus BL-
PFC hyp-g), 13 of the probe sets in the intersection were differentially expressed in the opposite 
direction, and none of the probe sets was differentially expressed in the same direction (Figure 9). 
The maximum and minimum expression FC values for probe sets sensitive to hypergravity were 
+3.60 and −6.46 with average figures of +2.00 and −2.00, respectively. The maximum and minimum 
expression FC for probe sets sensitive to microgravity were +1.82 and −2.09 with average figures of 
+1.33 and −1.46, respectively (Table 8). Altogether, compared to Jurkat T cells, U937 cells were in 
general more sensitive to gravitational alterations but similar as Jurkat cells also U937 cells were even 
more sensitive to hypergravity. 
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2.8. Rapid Alterations of HIF-Related Genes After 20 s of Altered Gravity in Human U937 Cells
In human U937 cells we were also able to detect a cellular response at the transcriptome level
to the hypergravity and vibration effects that is already present during the take-off of the parabolic
flight aircraft; 45 out of 375 analyzed probe sets (12%) were significantly differentially expressed
(comparison 1 g in flight (IF) versus hardware (H/W) 1 g ground control (GC)). In contrast to human
Jurkat T cells, HIF-related probe sets in U937 cells responded even more sensitive to gravitational
alterations. The hypergravity phase of the first parabola resulted in 104 differentially regulated probe
sets in the comparison BL-PFC hyp-g versus 1 g IF, a 2.3-fold increase compared to the initial response
(Table 7). Nine of the 45 initially responding probe sets, overlapped with the 104 regulated probe sets
identified during the first hypergravity phase (data not shown). In the direct comparison BL-PFC
hyp-g versus H/W 1 g GC 142 differentially expressed transcripts could be identified (Tables 7 and 8,
Figure 9). After the subsequent first microgravity phase, only 21 probe sets (µg versus BL-PFC hyp-g)
were differentially expressed (Tables 7 and 8, Figure 9). Note however, that in Jurkat T cells only
nine probe sets were sensitive under the same condition. No probe set could be excluded based on
the control comparison: differentially expressed in the same direction of the comparisons µg versus
BL-PFC hyp-g and BL-PFC hyp-g versus H/W 1 g GC (Figure 9). In the investigation of hypergravity
and microgravity double-sensitive probe sets (BL-PFC hyp-g versus H/W 1 g GC and µg versus
BL-PFC hyp-g), 13 of the probe sets in the intersection were differentially expressed in the opposite
direction, and none of the probe sets was differentially expressed in the same direction (Figure 9).
The maximum and minimum expression FC values for probe sets sensitive to hypergravity were
+3.60 and −6.46 with average figures of +2.00 and −2.00, respectively. The maximum and minimum
expression FC for probe sets sensitive to microgravity were +1.82 and −2.09 with average figures of
+1.33 and −1.46, respectively (Table 8). Altogether, compared to Jurkat T cells, U937 cells were in
general more sensitive to gravitational alterations but similar as Jurkat cells also U937 cells were even
more sensitive to hypergravity.
Table 7. Numbers of differentially expressed probe sets in response to altered gravitational conditions
in human U937 cells during parabolic flight. Direct comparisons between the sample groups are shown.
Primary Comparisons
Gene
Expression
1 g IF vs. H/W
1 g GC
BL-PFC hyp-g vs.
1 g IF
µg vs. BL-PFC
hyp-g
BL-PFC hyp-g vs.
H/W 1 g GC
up-regulated 15 61 6 75
down-regulated 30 43 15 67
total 45 104 21 142
Table 8. Definition and numbers of hypergravity- and microgravity-sensitive probe sets that are
differentially expressed in response to hypergravity or microgravity in human U937 monocytic cells
during parabolic flight.
Gene
Expression Hypergravity-Sensitive Probe Sets Microgravity-Sensitive Probe Sets
Significantly differentially expressed in the primary
comparison BL-PFC hyp-g vs. H/W 1 g GC
Significantly differentially expressed in the
primary comparison µg vs. BL-PFC hyp-g
NOT significantly expressed in the same direction
in the primary comparisons µg vs. BL-PFC hyp-g
and BL-PFC hyp-g vs. H/W 1 g GC
Number
average FC of
BL-PFC hyp-g vs.
H/W 1 g GC
min/max FC of
BL- PFC hyp-g vs.
H/W 1 g GC
Number
average FC µg
vs. BL- PFC
hyp-g
min/max µg vs.
BL- PFC hyp-g
up-regulated 75 2.00 3.60 6 1.33 1.82
down-regulated 67 −2.00 −6.46 15 −1.46 −2.09
total 142 - - 21 - -
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2.9. Strong Response of HIF-Related Genes in Human U937 Cells After 75 s of Hypergravity and after 300 s
of Microgravity
During the suborbital ballistic rocket based investigation of human U937 cells, 105 HIF-related
probe sets were differentially regulated after the launch phase (75 s hypergravity, comparison: BL-TX
hyp-g versus H/W 1 g GC, Tables 9 and 10, Figure 10). At the end of the following microgravity
phase (300 s), 38 probe sets were differentially expressed (µg versus BL-TX hyp-g, Tables 9 and 10,
Figure 10), representing 36% of the differentially regulated probe sets in hypergravity. Interestingly,
30 of the identified probe sets were hypergravity and microgravity double-sensitive (BL-TX hyp-g
versus H/W 1 g GC and µg versus BL-TX hyp-g) and were regulated in the opposite direction
(Figure 10). The expression fold change (FC) was in the range between +4.69 (up-regulation) and −2.08
(down-regulation), with average values of +1.92 and −1.74, respectively, for the hypergravity-sensitive
probe sets and between +2.48 (up-regulation) and−2.35 (down-regulation) with average values of +1.79
and −1.69, respectively, for microgravity-sensitive probe sets (Table 10). Analogous to Jurkat T cells,
HIF-1α-dependent gene expression in U937 is more affected in hypergravity than in microgravity.
However, in the latter cells the stronger and longer hypergravity phase did not much alter the number
of hypergravity sensitive probe sets.
Table 9. Numbers of differentially expressed probe sets in response to altered gravity conditions in
U937 cells during a suborbital rocket flight. Direct comparisons between the samples groups are shown.
Primary Comparisons
Gene Expression µg vs. BL-TX hyp-g BL-TX hyp-g vs. H/W 1 g GC µg vs. H/W 1 g GC
up-regulated 5 90 6
down-regulated 33 15 9
total 38 105 15
Int. J. Mol. Sci. 2019, 20, 436 15 of 31
Table 10. Definition and numbers of hypergravity- and microgravity-sensitive probe sets that are
differentially expressed in response to hypergravity or microgravity during TEXUS-49 sounding rocket
flight in human U937 cells.
Gene
Expression Hypergravity-Sensitive Probe Sets Microgravity-Sensitive Probe Sets
. Significantly differentially expressed in the primarycomparison BL-TX hyp-g vs. H/W 1 g GC
Significantly differentially expressed in the
primary comparison µg vs. BL-TX hyp-g
NOT significantly expressed in the same direction
in the primary comparisons µg vs. BL-TX hyp-g
and BL-TX hyp-g vs. H/W 1 g GC
Number
average FC of
BL-TX hyp-g vs.
H/W 1 g GC
min/max FC of
BL-TX hyp-g vs.
H/W 1 g GC
Number average FC µgvs. BL-TX hyp-g
min/max µg vs.
BL-TX hyp-g
up-regulated 90 1.92 4.69 5 1.79 2.48
down-regulated 15 −1.74 −2.08 33 −1.69 −2.35
total 105 - - 38 - -
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U937 cells during the TEXUS-49 sounding rocket flight. The different comparisons and resulting 
intersections for hypergravity and microgravity-sensitive probe sets are displayed as Venn-diagrams. 
In the circles numbers of probe sets are given that are differentially expressed with a p-value < 0.05. 
The red area shows the number of BL-controlled (BL-PFC hyp-g versus H/W 1 g GC) microgravity-
sensitive transcripts: differentially expressed in the comparison µg versus BL-TX hyp-g excluding 
i . t t for the identification of hyper- and microg avity-sen itive probe sets in human U937
cells during the TEXUS-49 sounding rocket flight. The different comparisons and resulting intersections
for hypergravity and microgravity-sensitive prob sets are displayed as Venn-diagrams. In the circles
numbers of probe set are giv n that are differenti lly expressed with a p-value < 0.05. The red area
s ows the number of BL-cont olled (BL-PFC hyp-g versus H/W 1 g GC) microgravity-sensitive
transcripts: differentially xpressed in the comparison µg versus BL-TX hyp-g excluding those
differentially expressed in the control comparison BL-TX hyp-g versus H/W 1 g GC that are regulated
in the same direction. For the abbreviations of the experiment group names see Table 1.
2.10. HIF-Related Probe Sets Were Primarily Differentially Regulated in Hypergravity in Human U937 T Cells
Figure 11 summarizes the number of differentially expressed probe sets in the parabolic flight
and suborbital ballistic rocket experiments. Similar fractions of the differentially expressed probe sets
were up- and down-regulated after 20 s of hypergravity, while only a small portion of probe sets were
differentially expressed after 20 s of microgravity with the majority of probe sets being down-regulated
(Figure 11a). Longer periods of hypergravity (75 s 5–7 g) resulted primarily in the up-regulation of
probe sets, while after longer periods of microgravity (5 min 10−4 g) only a small number of genes
remained differentially expressed, mainly down-regulated (Figure 11b).
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2.11. Dynamic Reaction and Adaptation Processes of Initially Differentially Altered HIF-Related Genes in
Altered Gravity in Human U937 Cells
The time course of differentially regulated probe sets of U937 cells in 1.8 g and 13.5 g of
hypergravity is summarized in Figure 12, and that of microgravity is summarized in Figure 13.
In hypergravity, a total number of 174 probe sets (46.4%) were not altered at all. Out of 142 initially
altered probe sets after 20 s in 1.8 g, only four probe sets (1.1%) were altered in the same direction
after 75 s in a maximum of 13.5 g. These 4 probe sets, belonging to 3 genes, were differentially
regulated in a continuous manner after 20 s and 75 s of hypergravity (Table 11), 38 probe sets (36.8%)
adapted. 59 probe sets (15.7%) were altered after 75 s in a maximum of 13.5 g, but not after 20 s of
1.8 g of hypergravity. In contrast to the high HIF-related response of differential gene expression in
hypergravity, there was only a minor cellular responsiveness after the microgravity phase. A total
number of 319 probe sets (85.1%) were not altered at all. Out of 21 initially altered probe sets after
20 s, one transcript (0.3%) was altered in the same direction after 300 s. This gene is listed in Table 12.
The remaining 20 initially differentially expressed probe sets (5.3%) adapted. A further 35 probe sets
(9.3%) were altered after 300 s, but not after 20 s of microgravity. Thus, in our experiments performed
with U937 cells, conducted in two different experiment platforms (19th DLR parabolic flight campaign
andTEXUS-49 suborbital ballistic rocket campaign), we identified in analogy to human Jurkat T cells
two pools of altered probe sets: a first one, which responded after seconds and adapted almost
completely within 5 min, and a second one, which appeared after at least 5 min of altered gravity.
Int. J. Mol. Sci. 2019, 20, 436 17 of 31
An inter-platform comparison between the parabolic flight and sounding rocket experiments and
between different cell types identified pyruvate dehydrogenase kinase 1 (PDK1) as highly responsive
to gravitational changes in human U937 myelomonocytic cells and in Jurkat T cells.
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Figure 12. Time course of differential expression of 385 probeset IDs in human U937 cells
after hypergravity exposure (list f probe sets in Supplementary Table S1). Human U937 cells
were exposed to 20 s and 75 s of hypergravity. The probe sets are grouped according to their
regulation aft r the two exposure times. Continuous response means that the probe sets are eith r
up-regulat d or down-regulated at both time p int . Adaptation is either the disappea ance of
the hypergravity-ind ced effec or regulation in he opposite direction after 75 s. Late response is a
regulation that only appears after 75 s. For the abbreviations of the experiment group names see Table 1.
Table 11. Differentially regulated probe sets in a continuous manner in 20 s and 75 s of hypergravity
identified in human U937 cells in the 19th DLR parabolic flight and TEXUS-49 suborbital ballistic rocket
campaigns. Four probe sets, belonging to three genes were differentially regulated with respect to both
altered gravity platforms. Plus: significantly up-regulated probe sets (p-value < 0.05). FCs are ratios
between the averages of linear expression values. If the ratio is <1, FC is calculated as the negative
reciprocal of the ratio. For the abbreviations of the group names see Table 1.
Gene Name Gene ID Probe Set ID
Fold Change 19th
DLR PFC BL-PFC
hyp-g vs. H/W 1 g GC
Fold Change
TEXUS-49 BL-TX
hyp-g vs. H/W 1 g GC
SERPINE1 5054 NM_000602 +2.16 + 1.50
PDK1 5163 BC039158 +1.30 +1.48
PDK1 5163 NM_002610 +1.23 +1.62
SLC2A3 6515 NM_006931 + 1.81 +1.50
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campaigns. One probe set, belonging to one gene was differentially regulated with respect to both
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Gene Name Gene ID Probe Set ID
Fold Change 19th
DLR PFC µg vs.
BL-PFC hyp-g
Fold Change
TEXUS-49 µg vs.
BL-TX hyp-g
IL1B 3553 NM_000576 −1.65 −1.43
3. Discussion
In our study e found that compared to normogravitational conditions, HIF-1α and
hypoxia-inducible transcripts were differently regulated in early response to altered gravity, whereas
HIF-1α-dependent gene expression adapted rapidly to an altered gravitational environment. In our
previous studies, we detected profound alterations in the transcriptome after 20 s of microgravity or
hypergravity and rapid adaptation responses after 5 min and assumed that gravitational forces are
rapidly and constantly transduced into the nucleus [37,38,40]. The response of HIF-related genes to
gravitational force changes is more frequent in hypergravity than in microgravity, which corresponds
with the genome-wide effects of hypergravity compared to microgravity [37,38]. The question arises
how the observed rapid changes in HIF-1α (mRNA and protein) and HIF-dependent gene expression
(mRNA) in response to gravitational alterations are possible. Recent data have shown that RNAs
are typically distributed inside cells not just by diffusion but are rather by an active, specific and
well controlled transport leading to defined enrich ent of selected mRNAs in distinct regions of the
cell [41]. This is achieved by complex and highly dynamic RNA–protein interactions that start already
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in the nucleus directly after and even during transcription. Then after export of the mRNAs into the
cytoplasm they are specifically protected from degradation by being complexed with another set of
proteins or sometimes locally degraded to deplete certain areas of the cell from defined mRNAs [41].
More important is the fact that the well-controlled and specific intracellular transport is highly
dependent on the cytoskeleton i.e., the actin network. mRNAs are building large particles with
proteins including motor-proteins that ensure active movement on actin fibers to carry the RNAs
to pre-defined regions in the cells [41]. Once the RNAs reached their destination they are unloaded
and anchored to other specific proteins that aid the RNAs to get in contact with the translation
machinery [42,43]. Of note, also proteins are transported actively using cytoskeleton-associated
mechanisms back and forth through the cells [44]. This includes also transcription factors that may be
synthetized remote in the cell and then transported back to the nucleus, a mechanism involved for
transferring information from distant parts of the cell to the nucleus [41] i.e., in neurons from dendrites
to the nucleus. Since all these transport events are significantly dependent on the cytoskeleton
that is rearranged quite quickly in response to mechanical stress [45], we performed phalloidin
staining for visualization of the cytoskeleton in MDA-MB-468 cells subjected to gravitational changes.
Indeed, these cells showed alteration of the cell shape and actin fiber pattern already after a single
hypergravity–microgravity–cycle (Figure 14). Of note, this effect was even more pronounced in cells
subjected to 15 parabolic maneuvers. This observation of altered cytoskeleton might be accompanied
by an altered intracellular RNA and protein transport and at least partly explaining why the expression
of HIF-1α and its target genes which are so quickly altered in response to gravitational alterations.
However, intense additional work is necessary to get a better insight as to the role of the cytoskeleton
and intracellular RNA and protein transport in hyper- and / or microgravity.
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Theoretical explanations for rapid transcript regulation require rapid force transduction into the
nucleus, which is likewise theoretically possible and has been demonstrated for other mechanical
forces than gravity [46]. It is possible that gravitational forces are rapidly and constantly transduced
into the nucleus, acting as an omnipresent condition in the nuclear and chromatin structure and
subsequently resulting in homeostasis of gene expression [37].
Hypoxic conditions during space missions are often caused by extravehicular activities (EVAs).
A critical issue of spacesuits required for EVAs is the balance between suit air pressure and oxygen
concentration in order to ensure an appropriate oxygen partial pressure (pO2 = air pressure × O2
concentration in the air) for the astronaut. Whereas high suit pressurization reduces mobility of the
astronauts, increased oxygen concentrations that would allow lowering the air pressure increase
the risk of flammability. Moreover, a markedly reduced suit pressure compared to the spacecraft’s
atmosphere may induce decompression sickness (DCS) that per se might induce tissue hypoxia.
To avoid DCS, pre-breathing of 100% oxygen is recommended to wash out nitrogen that is dissolved in
the body fluids. The time necessary for pre-breathing pure oxygen in order to considerably reduce the
risk of DCS depends on the desired suit pressure and duration for the planned EVA [47] as well as the
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atmospheric pressure the astronauts experienced in the spacecraft before EVAs [48]. Owing to this, the
oxygen concentrations and atmospheric pressures inside the space suit need to be variable ranging
from 34% to 100% oxygen and 56.5 to 29.6 kPa, respectively. Although this might avoid hypoxia during
EVAs, astronauts may live for at least 12 h at a lowered cabin pressure from its nominal pressure of 101.2
kPa to 70.3 kPa prior to the EVA to reduce considerably pure oxygen pre-breath time, a compromise
that puts the astronaut into mild hypoxia, later allowing a suit pressure that is low enough for an
acceptable degree of mobility for the planned task during EVA. However, the combination of hypoxic
exposure with microgravity as well as reduced atmospheric pressure aggravates the symptoms of
hypoxia [49] such as vision impairment, edema of the visual nerve papilla and increased intracranial
pressure. This symptom complex is called VIIP-Syndrome (visual impairment/intracranial pressure
syndrome) and is considered to be a major risk of manned space flight. Moreover, these symptoms are
often associated with headache, nausea, vomiting, sleep disturbance and poor physical performance.
The latter combination of symptoms is also typical for acute mountain sickness (AMS) that occurs
after rapid ascent to high altitude [50]. It appears that the combination of hypoxia (more prominent
in AMS then in the VIIP-syndrome) with microgravity (only in VIIP) aggravates especially altered
hemodynamics in the intracranial circulation [49] and disturbance of the cerebrospinal fluid system
due to the loss of hydrostatic pressure gradients between the head and the rest of the body [51].
Nevertheless, although the detailed patho-physiology of VIIP and AMS is still not fully understood,
a large body of evidence suggests that a dysregulated cellular response to hypoxia is involved [52].
Regarding the symptoms of VIIP and AMS, the oxygen-dependent regulated gene vascular endothelial
growth factor (VEGF) is of central interest for the following reasons: first, it is already up-regulated
by rather mild tissue hypoxia [53]. Second, initially after its discovery this signaling protein has been
formerly termed “vascular permeability factor” because the first step of its action to stimulate the
growth of new capillaries (angiogenesis) in hypoxic tissues is to weaken the mechanical interactions
between endothelial cells [54,55]. Third, in particular in the brain and other neuronal tissues such
as the retina and larger nerves such as the optic nerve this has unfavorable consequences as the
disruption of cell-cell-interaction of brain endothelial cells disintegrates the blood brain barrier (BBB).
Consequently, extravasation of blood plasma and water occurs leading to the clinical symptom of
brain edema and increased intracranial pressure with subsequent impairment of brain function such
as nausea or vomiting, vision changes and headache as seen in VIIP and AMS. Finally, HIF-signaling
as well as VEGF expression, particularly in immune cells, can be induced independent of hypoxia,
e.g., through inflammatory stimuli or growth factors [56,57]. Moreover, it is likely that transcription
factors, which are involved in force transduction interact with the HIF pathway within a complex and
multi-layered response to gravitational changes. In consequence, regarding the health of astronauts, it
has to be taken in account that the function of the immune system is affected by HIF signaling and that
this might also be aggravated by other environmental factors inherent to space flights [11–13,58–60].
In our experiments, we utilized the robust multichip average (RMA) algorithm combined with a
quantile normalization of the microarray data, where the background noise is subtracted in order to
avoid false positive results based on a low signal and high background. Furthermore, the large number
and homogeneity of the applied samples resulted in a low variance within the sample groups and a
high sensitivity of the applied method. Arbitrary definition of the cut-offs in gene expression analysis
is usually made without underlying biological arguments [61–64] and, therefore, is not regarded
as an adequate test procedure [65,66] because it does not include variance and an accompanying
level of confidence [65,67,68]. Thus, we applied two sample t-test of the null hypothesis and used
the p-value for the identification of significantly differentially regulated genes, which is frequently
applied in microarray studies [69] and has many benefits in comparison to the fold change method.
Despite the fact, that we did not select differentially regulated genes according to their fold change,
maximum and minimum values were obtained for Jurkat T cells and U937 cells on parabolic flight
and suborbital rocket experiments that were usually above/below +/−1.3 reaching fold change
values up to +4.69 and −6.46. Interestingly, we detected that the pyruvate dehydrogenase kinase 1
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(PDK1) was constantly and stably up-regulated in hypergravity, in different flight campaigns and in
different cell types, underscoring a very high level of evidence. The pyruvate dehydrogenase kinase 1
(PDK1), crucially involved in the activation of T cells as well as macrophages, is one of the four family
members of protein kinases that phosphorylate and inactivate pyruvate dehydrogenase (PDH) [70],
thereby shunting pyruvate away from the TCA cycle toward glycolysis [71]. PDK1 expression results
in the inhibition of pyruvate dehydrogenase a (PDHa) subunit through phosphorylation and is a
direct target of HIF-1 [72]. Consistent with this finding, PDK1 is overexpressed in tumors in which
HIF-1 is stabilized [73]. Also in our experiments, we could confirm that PDK1 up-regulation was
accompanied by HIF-1α upregulation, both induced through an increased gravitational force. In line
with this we found also a constant and stable up-regulation of SLC2A3 that is the glucose transporter 3
(GLUT3). Whereas lymphocytes express GLUT1 and GLUT3 in equal amounts, monocytes express
markedly more GLUT3. Differentiation of monocytes into macrophages induced significant GLUT
3 and GLUT 5 protein expression [74]. Thus, induction of SLC2A3 could argue for a macrophageal
activation in hypergravity. SERPINE1 or plasminogen activator inhibitor-1 (PAI-1) demonstrated a
stable hypergravity-induced up-regulation. PAI-1 is the principal inhibitor of tissue and urokinase
plasminogen activator (tPA, uPA), and hence an inhibitor of fibrinolysis. PAI-1 has pro-tumorigenic
functions through stimulation of angiogenesis and inhibition of apoptosis as well as recruitment
and polarization of macrophages to tumors [75]. On the other hand, IL1b was constantly and stable
down-regulated in microgravity parallel to the down-regulation of HIF1a. HIF1a-dependent induction
of the pro-inflammatory cytokine IL1b can even occur without hypoxia, e.g., by stimulation with
lipopolysaccharides (LPS) that can lead to intracellular succinate accumulation [76]. Succinate itself
inhibits prolyl-hydrogenases [77] that are crucial for continuous normoxic HIF1a degradation. Thus,
increases of intracellular succinate per se or as a result of disturbance of the tricarboxylic acid cycle
may induce HIF1a accumulation and subsequent hypoxia-inducible gene activation even in normoxia.
Cells were cultured under standard conditions (air with 5% CO2) before the experiments.
Although the sealed hardware used for all experiments (custom-made parabolic flight and suborbital
rocket mission hardware) did not allow for oxygen and CO2 measurements, we do not expect any
significant differences in the gas concentrations between the experimental groups due to the very short
intervals between the fixation time points: the interval between the fixation of the 1 g, hyper-g and
µg group was less than 0.5% of the total time period in the sealed cell culture system for parabolic
flight experiments, and less than 1% for suborbital ballistic rocket experiments. Since the experiments
were not conducted in hypoxia, we assume that the observed differential gene expression was mainly
hypoxia-independent. The regulation of HIF-1a by continuous degradation in the presence of oxygen
and stabilization in hypoxia is well investigated. However, there is evidence that HIF-1a is specifically
regulated independently of the intracellular oxygen concentration, mostly at the transcriptional,
but also at the post-transcriptional (e.g., by microRNAs), as well as at the translational level. Many
regulators of HIF-1a under normoxia have been identified, e.g., IL-18, IL-6, TNF-α, LPS, angiotensin II,
thrombin, hepatocyte growth factor and glucose [78].
Hypoxia has long been shown to stimulate NF-κB-mediated signaling [79], and several pieces of
evidence indicate that both HIF and NF-κB proteins are redox-sensitive crucial regulators of metabolic
adaptation [15], regulated by the same oxygen sensors [33]. Transcriptional activation of HIF-1α by
IKKβ-responsive NF-κB is a crucial precursor to posttranscriptional stabilization and accumulation
of HIF-1α protein [80]. Previous studies have demonstrated that NF-κB signaling pathways are also
regulated by altered gravity: Whereby inhibition of nuclear translocation of NF-κB has been observed
as the predominant response to simulated microgravity, in either stimulated or non-stimulated Jurkat
T cells [81], the Rel/NF-κB pathway in T cell activation was inhibited in long-term micogravity
by real microgravity during an International Space Station (ISS) experiment [82]. In our study we
detected a short-term regulation of HIF transcripts in the time frame of seconds to minutes [83], that is
different from changes in HIF-1α-dependent gene expression that require several hours [15]. Therefore,
it is tempting to speculate on the impact of long-term gravitational changes on HIF-dependent
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transcriptional response, which has not been investigated so far in microgravity. A recent study
investigated brains of rats exposed to 28 days of hindlimb unloading / tail-suspension as simulation
of microgravity and found HIF-1α, HIF-2α and several downstream targets upregulated as well as
signs of increased oxidative stress [84]. The NF-κB pathway is known to play a role in many of the
health risks associated with spaceflight and sufficient evidence has been accumulated to indicate that
the NF-κB pathway is altered by either microgravity or space radiation [85]. We assume a synergistic
relationship between HIF and NF-κB as regulator of immunity in altered gravity conditions. Because
of the short half-life, HIF could represent an attractive pharmacological target for counteracting the
immune system deterioration during space flights and, therefore, mitigating the risk for exploration
class missions.
4. Materials and Methods
Material and methods have been described in our previous studies [37,38,40].
4.1. Cell Culture
The human cell lines U937 (myelomonocytic cells, ATCC CRL-1593.2, Manassas, VA, USA)
and Jurkat (T cells, ATCC Clone E6-1, TIB-152, Manassas, VA, USA) were cultured under standard
cell culture conditions as described previously [38], In summary, cells were kept in a standard cell
culture incubator (5% CO2, 100% humidity, 37 ◦C), subcultured every second day and reseeded
to a density of 0.2 × 106 cells/mL. For quantification and assessment of cell viability cells were
stained with trypan blue. Viability was between 97 and 100%. Population doubling time was
between 24 and 28 h. MDA-MB-468 breast adenocarcinoma cells (ATCC HTB-13, Manassas, VA,
USA) were cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing high glucose levels
(4.5 g/L) (Gibco/Life Technologies, Hessen, Germany) and supplemented with 10% Fetal Bovine Serum
(10270-106, Gibco/Life Technologies, Hessen, Germany) and 1% penicillin/streptomycin (Gibco/Life
Technologies, Hessen, Germany). Cells were cultured of a density of 60–70% and medium exchange
was performed every 48 h. The viability of all cells in culture was frequently checked.
4.2. Parabolic Flight Experiment Platform
As already delineated [37–40,81,86,87], parabolic flights represent a suitable platform for the
investigation of initial and primary effects of altered gravity in mammalian cells omitting interfering
effects of secondary signaling cascades. During a parabola maneuver different gravitational conditions
are experienced: 1 g, 1.8 g, and microgravity (µg, 10–2 g to 10–3 g). We designed a custom made
parabolic flight hardware that allows cell culture experiments on board the Airbus A300 ZERO-G
(F-BUAD) and the Airbus A310 ZERO-G (Reg F-WNOV) [15,27–40,81,84]. The experimental system
is made of three units: (1) a storage rack for pre-experiment storage at 36.5 ◦C; (2) a cooling rack for
post-experiment storage at 4 ◦C; and (3) a working rack for experiment execution and cell culture
handling (Supplementary Figure S1). In total, up to 54 individual experiments can be performed
during each flight including required control experiments during the 1 g phase before the first parabola.
The fluid injection for cell activation, lysis or fixation works automatically and is pre-programmed.
However, the exchange of the single-experiment containers was performed manually. This hardware
was used to investigate altered gravity based gene expression changes in human U937 and Jurkat T
cells during the 19th and 23rd DLR PFCs. Experiments were only conducted during the first parabola
to ensure that the detected differential gene expression levels were a result of the effect of gravitational
change rather than an accumulated long-term effect.
Regarding the MDA-MB-468 cells we developed smaller autarkic cell-containers (20 × 15 × 6 cm)
that contained heating pads to keep the cells warm at 37 ◦C. Fife of these cell-containers were used
at the first Swiss Parabolic Flight Campaign (Dubendorf Military Airport), each equipped with
6 IBIDI-slides (µ-Slide I Luer, IBIDI, Martinsried, Germany) to enable six simultaneous cell culture
experiments for each desired condition (Supplementary Figure S2). Changing of the fluids inside
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the compartment with the cells (cell culture medium, fixing solution) was achieved with two levers
allowing two fluid exchanges simultaneously in all six experiments. Two containers (one for immune
cytochemistry, one for protein analysis) were used as control, e.g., the experiments were terminated by
manual injection of fixing solutions just before the first parabola was initiated. The experiments of
the next two containers (one for immune cytochemistry, one for protein analysis) were finished after
the first parabola i.e., at the end of the first microgravity phase. The experiments in the remaining
container (three slides for immune cytochemistry, three for protein analysis) were terminated after the
15th parabola.
4.3. Preparation and Execution of the Parabolic Flight Experiments
The preparation of U937 cells and Jurkat T cells for the parabolic flight experiments have been
described previously [37–40]. Briefly, 1 × 107 U937 cells or Jurkat T cells in 10 mL Medium were filled
into 200 mL Nutrimix bags (B. Braun Melsungen, Melsungen, Germany). Cell samples were then
transported to the pre-flight preparation laboratories at the NOVESPACE premises in Bordeaux, France,
stored overnight at 36.5 ◦C, and directly used for the experiment the next morning. The pre-flight
experiment preparation included the integration of the cells in the Nutrimix bag into a solid plastic
container to avoid the risk of fluid spillage in the aircraft in case of leakage of the hardware.
In-flight, the cells were rapidly lysed at the desired time point (1 g IF samples 5 min before the first
parabola, 1.8 g and microgravity samples during the first parabola) by fast injection of five volumes of
RLT buffer (Qiagen, Hilden, Germany). 1 g ground controls were performed after landing inside the
aircraft in the original experiment hardware. Total RNA was isolated from all experiment samples
directly after the flight. A schematic overview of the experiment design is shown in Supplementary
Figure S1. During the 19th DLR PFC, RNA from 28 U937 cell samples (6 × H/W 1 g GC, 8 × 1 g IF,
6 × BL-PFC hyp-g, 8 × µg, Table 1) was isolated and during the 23rd DLR PFC RNA from 24 Jurkat T
cell samples (6 × 1 g ground controls, 6 × 1 g in-flight controls, 6 × 1.8 g and 6 × µg) were purified.
MDA-MB-468 cells were grown in the home laboratory already inside the IBIDI-slides. At the
morning of the flight experiment the IBIDI-slides were mounted into pre-warmed (37 ◦C) cell containers
equipped with heating pads and placed in welded plastic bags to prevent possible leakage of fluids
in the aircraft. Then they were transported to the airfield in pre-warmed and isolated containers to
keep them at 37 ◦C and mounted into the aircraft. About 40min before the first parabola the medium
inside the IBIDI-slides was exchanged and two experimental sets (i.e., six each individual experiments
in two containers) were terminated just before the start of the first parabola, two other experimental
sets at the end of the first microgravity phase and the last experimental set after the 15th parabola by
exchanging the cell culture medium with fixing solution (either 4% formalin solution or TRI-Reagent
(R) (Fisher Scientific, Portsmouth, NH, USA)).
4.4. RNA Isolation after the Parabolic Flight
The RNA isolation has been described in detail in [37–40]. Briefly, after the landing of the airplane,
the experiment hardware was disassembled, the lysed cell suspension was sheared and applied on an
RNA maxi column (Qiagen, Hilden, Germany) with the help of a Qiavac 24 plus vacuum manifold
(Qiagen, Hilden, Germany). RNA maxi columns were the centrifuged at 3220× g for three min at room
temperature and washed with 15 mL of RW1 buffer and two times 10 mL of RPE buffer. Each washing
step was followed by centrifugation at 3220× g for seven to ten min at room temperature. Total RNA
was eluted with 600 µL of pre-warmed RNase-free water (Qiagen, Hilden, Germany) and four min
centrifugation at 3220× g at room temperature. Extracted RNA was stored and transported on dry ice
until RNA processing for microarray analysis.
4.5. Western Blotting and Cytoskeleton Visualisation of MDA-MB-468 Cells
Protein extracts of the cells were separated by sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) (10%) and after being transferred to a nitrocellulose membrane
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immuno-probed using an anti HIF-1α antibody (1:1000, Novus Biologicals, Centennial, CO, USA).
The resulting signal was quantified using an image analyzer (MCID) as described [36] and normalized
to the total protein concentration determined from the optical density of the Coomassie Blue stained
nitrocellulose membranes as described [88]. Normalized optical densities of the HIF-1α bands were
compared using a two-tailed t-test. Significant differences were considered at p < 0.05.
For phalloidin staining the cells were washed 3 times with PBS containing 0.1 M glycine and
0.1% Triton-X-100 (Sigma-Aldric, St. Louis, MO, USA). Then the cells were incubated in phalloidin
solution (phalloidin-rhodamine conjugate, Abcam) for 60 min. Then the cells were rinsed with PBS
and observed using a fluorescence microscope (Axio-Imager, Zeiss).
4.6. Technologische Experimente unter Schwerelosigkeit (TEXUS)-49 Suborbital Ballistic Rocket Experiment
TEXUS-49 was a suborbital ballistic rocket mission. The vehicle consisted of a two-stage VSB-30
rocket motor and the experiment payload. The rocket was launched on 29 March 2011 at 06:01 from the
ESRANGE (European Space and Sounding Rocket Range) Space Center near Kiruna, Sweden. Details
of the flight profile included: (1) altitude: 268 km, (2) total microgravity time: 378 s (10−5 g), (3) 6.3 g
first-stage peak thrust acceleration, (4) 5.03 g mean thrust acceleration, (5) first-stage burnout at 12.3 s,
(6) engine separation at 13.6 s, (7) 13.5 g second-stage peak thrust acceleration, (8) 7.3 g mean thrust
acceleration, (9) burnout at 43.0 s, (10) yo-yo despin at 56.0s, and (11) engine separation at 59.0 s.
4.7. TEXUS-51 Suborbital Ballistic Rocket Experiment
TEXUS-51 was a suborbital ballistic rocket mission. The vehicle consisted of a two-stage VSB-30
rocket motor and the experiment payload. The rocket was launched on 23 April 2015 at 09:35 from
the ESRANGE Space Center. Details of the flight profile included: (1) altitude: 258 km, (2) total
microgravity time: 369 s (10−5 g), (3) 8.1 g first-stage peak thrust acceleration, (4) 5.1 g mean thrust
acceleration, (5) first-stage burnout at 12.1 s, (6) engine separation at 13.4 s, (7) 12.6 g second-stage
peak thrust acceleration, (8) 6.7 g mean thrust acceleration, (9) burnout at 43.2 s, (10) yo-yo despin at
56.0 s, and (11) engine separation at 59.0 s.
4.8. Procedures for the TEXUS Mission
The complete procedures for the TEXUS mission have been described previously in [37–40]. Briefly,
one experimental unit consisted of three syringes. One syringe was filled with the cell suspension (U937
or Jurkat T cells), a second syringe was filled with cell culture medium and a third syringe was filled
with the lysis solution (Trizol LS, Life Technologies, Germany). All three syringes were connected via a
T-piece and contained small plugs at the outlet ports to avoid premature mixing of fluids. The three
syringe-containing experiment units were integrated into temperature-controlled and vacuum-resistant
containers (Supplementary Figure S1d). Syringes were activated during the experiment automatically
at pre-defined time points via a pneumatic system. The experiment preparation started 7 h before
launch and the experimental units were integrated between 1:15 h and 0:45 h before liftoff (late access
port). During the experiment, the sample temperature was controlled and set to 36.5 ◦C ± 0.5 ◦C until
lysis. After landing, recovery of the payload, and disassembly of the experiment units, purification of
total RNA immediately started. The isolated RNA was stored and transported on dry ice and kept at
−80 ◦C until processing for microarray analysis.
4.9. Experimental Preparation and Integration for TEXUS Experiments
Cells were cultivated on site under standard conditions using the ESRANGE laboratory facilities.
The preparation of U937 cells and Jurkat T cells for the TEXUS experiments have been described
previously [37–40]. Briefly, 3 mL plastic syringes were filled with 2.5 × 107 U937 cells or Jurkat
T cells shortly before the handover of the samples to the launch team. A second set of syringes was
filled with 0.3 mL cell culture medium and a third set of syringes was filled with 1mL of Trizol LS
(Life Technologies, Hessen, Germany). The three syringes representing one experimental unit were
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mounted on a sterilized plastic T-block with a connecting tubing system. Experiment units were stored
at 36.5 ◦C ± 0.5 ◦C until integration or until execution of the ground controls. During the experiment
sequence, first 0.3mL of cell culture medium was injected to the cells and then 1mL of Trizol LS for cell
lysis according to the pre-programmed experiment protocol. Altogether, 18 samples were executed
during the TEXUS-49 mission: 6 × H/W 1 g GC, 5 × BL-TX hyp-g, 7 × µg (see Table 1). During
the TEXUS-51 mission, the in-flight hardware contained additionally and 1 g on-board centrifuge.
Furthermore, 1 g cell culture controls were included on the ground. In total, 39 samples were processed
for the TEXUS-51 mission: 7 × 1 g ground cell culture controls (CC), 7 × H/W 1 g GC, 9 × 1 g 1 g IF,
and 7 × BL-TX hyp-g and 9 × µg.
4.10. RNA Isolation After TEXUS Landing
A detailed protocol is given elsewhere [37–40]. In summary, samples (1.8 mL) were sheared three
times by passing them through a 20 G needle (B. Braun Melsungen, Melsungen, Germany), mixed
with 0.2 mL chloroform and centrifuged. The upper phase was mixed with 4 mL RLT buffer and 3 mL
ethanol and processed using a RNA Midi column (Qiagen, Hilden, Germany). After elution from the
column, RNA was transported and stored at −80◦C.
4.11. RNA Sample Processing and Microarray Data Analysis for U937 Cells
RNA was quality and quantity was assessed with a Nanodrop 1000 (Thermo Scientific). 260/280
nm ratios were between 1.9 and 2.1. An Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara,
CA, USA) was used to measure the RNA integrity number (RIN) and only RNA samples with
values >8.7 were submitted to microarray analysis. For cy3-labeling the “Low RNA Input Linear
Amplification Kit, PLUS, One-Color” (Agilent Technologies) was used, and for hybridization (17.5 h)
the “Gene Expression Hybridization Kit” (Agilent Technologies, USA) was applied. Washing and
scanning was done in the Micro Array Scanner G2505B (Agilent Technologies, USA), imaged files
were processed with the NimbleScan Software 2.6 with using default setting of the Robust Multi-Array
Analysis (RMA). Averages were made from the normalized microarray data from one experimental
group, and ratios between two experimental groups were calculated with Excel 2013. In case the ratio
is >1 it equals the fold change, if the ration is <1 the fold change is the negative reciprocal of the ratio.
Fold changes were considered to represent a significantly differential expression if the t-test p-value
was <0.05.
4.12. RNA Sample Processing and Microarray Data Analysis for Jurkat T Cells
RNA sample processing and microarray data analysis were described in detail elsewhere [37–40].
In summary the Affymetrix GeneChip® Human Transcriptome Array 2.0 (Affymetrix United Kingdom
Ltd., High Wycombe, UK) which contains 44,699 protein coding and 22,829 non-protein coding genes,
was used. Only RNA which passed the quality criteria of 260/280 nm ratio between 1.97–2.04 and
RNA integrity numbers (RIN) >8.2 was analyzed.
100 ng of total RNA was used as starting material for the preparation of fragmented and
biotinylated DNA targets according to the standard Affymetrix WT PLUS Reagent Kit protocol
(Affymetrix GeneChip® WT PLUS Reagent Kit, 902,280). The generated DNA targets were hybridized
(17 h, 45 ◦C) onto GeneChip Human Transcriptome Arrays 2.0 and chips were washed and stained
according to a standard protocol (Affymetrix GeneChip Wash, Stain and Scan Kit, 900,720) in the
Affymetrix Fluidics Station 450 and scanned with the Affymetrix 3000 7 G scanner. The data analysis
was performed with the Affymetrix Expression Console and Transcriptome Analysis Console. We used
the robust multi-array average (RMA) algorithm combined with a quantile normalization of the
microarray data [89]. In this approach, the background noise is subtracted in order to avoid false
positive results based on a low signal and high background. A one-way analysis of variance (ANOVA)
was used the determine gene expression differences. The log 2 values of the fluorescent intensities
for selected genes of interest were back calculated to linear values. The average values were then
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calculated and fold changes with a p-value (one-way ANOVA) of <0.05 were considered to represent a
significant differential gene expression. The large number and homogeneity of the applied samples
resulted in a low variance within the sample groups and a high sensitivity of the applied method.
4.13. Selection of Array Probe sets for Analysis of HIF-1 Signaling Pathway Related Genes
A list of 176 genes relevant for HIF-1 signaling was compiled comprising the 100 genes
from Kyoto Encyclopedia of Genes and Genomes (KEGG) database entry hsa04066, “HIF-1
signaling pathway–Homo sapiens (human)” (https://www.genome.jp/dbget-bin/www_bget?
pathway+hsa04066) and 76 genes which are known from the literature to also interact with HIF-1
signaling. All probe sets from the NimbleGen expression microarray and all Transcript IDs from the
Affymetrix GeneChip® Human Transcriptome Array (for simplicity also referred to as probe sets in this
paper) matching in gene symbol and Entrez ID Number (current assignment) were selected. In case
the gene symbol and Entrez ID within the annotation of the arrays were different from the current
annotation, the probeset was only included if validated by the current annotation. All of the selected
probe sets and transcript clusters are shown in Supplementary Table S1.
4.14. Intra-Platform and Inter-Platform Comparisons
To elucidate the sensitivity of probe sets to microgravity, intersections of the primary comparison
and the respective control-comparison were built. All probe set which were differentially expressed in
the same direction in the primary comparison and in the control comparison were not considered to be
microgravity-sensitive. Intersections between the pools of gravisensitive probe sets of parabolic flight
and of suborbital ballistic rocket flight were made to investigate gravisensitivity over time.
4.15. Data Availability
Microarray data sets are accessible under www.ncbi.nlm.nih.gov/projects/geo (Gene Expression
Omnibus (GEO) repository), under accession no. GSE94256 for Jurkat T cell and under accession no.
GSE101309 for U937 cells.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/2/
436/s1.
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